Annovis Bio still climbing . . .

[redhawk1]

. . . on Wall Street! Here’s another interesting article about their current and future plans!

genengnews.com/insights/ann...

[jeffreyn]

"In a year or two, when we do the longer-term studies in humans, we hope to see the second step—the drug will prevent nerve cell death."

"In September, if we get approval to move into either Phase III or Phase II-B, we will start these trials later in the year."

Given the stage that they are at with ANVS401, this timeframe seems reasonable to me.